Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations
Status:
Terminated
Trial end date:
2021-01-12
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well targeted therapy works in treating patients with
incurable non-small cell lung cancer with a genetic mutation. Giving drugs that target other
genetic mutations or other specific proteins may work better when a patient has cancer caused
by a driver mutation and the treatment that targets that mutation stops working.